JAIDS Journal of Acquired Immune Deficiency Syndromes · 2013 · 38 citations · 16 references
DRV/r did not increase 17-BMP exposure, whereas RTV alone produced a statistically significant but clinically inconsequential 2-fold increase in 17-BMP exposure. Adrenal suppression was not observed in any of the study groups. These data suggest that BDP can be safely coadministered with DRV/r and likely other RTV-boosted protease inhibitors.
16
Peter T. Daley‐Yates, Alison C. Price, Jonathan R. Sisson et al. · British Journal of Clinical Pharmacology · 2001 · 220 citations · Full text
Health Care–Associated Bloodstream Infections
Nicola M. Zetola · Annals of Internal Medicine · 2003 · 167 citations
Katherine Samaras, Sarah Pett, Andrew Gowers et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 130 citations · Full text